James McLaren is Managing Director at TM Capital Corp., one of Oaklins’ US member firms. He is also co-head of Oaklins’ Medical Devices Group. James brings his extensive background in the healthcare industry to the firm’s newly formed TM Asante Healthcare Partners. He joined TM Capital from Asante Partners, which he founded more than twenty years ago to provide quality strategic advice to middle-market healthcare companies. Previously, James had a twenty-year career advising corporate clients at Goldman Sachs, where he served as head of European Corporate Finance in London and of International Corporate Finance in New York, leading teams that executed significant global transactions.
James earned a BA with Honors in Economics from Oxford University. He is an advisory board member of Radius Ventures, a New York-based firm focused on the healthcare industry, and was a director at Montreal-based RTP Pharma until its sale to Skye Pharma.
© Oaklins. All rights reserved. Oaklins refers to Oaklins International Inc. and/or one of its member firms, each of which is a separate legal entity. Please see www.oaklins.com/legal for further details.